AU2002348103A1 - Methods for gene transfer using pseudotyped lentiviruses - Google Patents

Methods for gene transfer using pseudotyped lentiviruses

Info

Publication number
AU2002348103A1
AU2002348103A1 AU2002348103A AU2002348103A AU2002348103A1 AU 2002348103 A1 AU2002348103 A1 AU 2002348103A1 AU 2002348103 A AU2002348103 A AU 2002348103A AU 2002348103 A AU2002348103 A AU 2002348103A AU 2002348103 A1 AU2002348103 A1 AU 2002348103A1
Authority
AU
Australia
Prior art keywords
methods
gene transfer
pseudotyped lentiviruses
pseudotyped
lentiviruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002348103A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of AU2002348103A1 publication Critical patent/AU2002348103A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/14011—Filoviridae
    • C12N2760/14211—Marburgvirus, e.g. lake Victoria marburgvirus
    • C12N2760/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2002348103A 2001-10-26 2002-10-28 Methods for gene transfer using pseudotyped lentiviruses Abandoned AU2002348103A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35322101P 2001-10-26 2001-10-26
US35643601P 2001-10-26 2001-10-26
US60/356,436 2001-10-26
US60/353,221 2001-10-26
PCT/US2002/034545 WO2003035849A2 (en) 2001-10-26 2002-10-28 Methods for gene transfer using pseudotyped lentiviruses

Publications (1)

Publication Number Publication Date
AU2002348103A1 true AU2002348103A1 (en) 2003-05-06

Family

ID=26997853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002348103A Abandoned AU2002348103A1 (en) 2001-10-26 2002-10-28 Methods for gene transfer using pseudotyped lentiviruses

Country Status (2)

Country Link
AU (1) AU2002348103A1 (en)
WO (1) WO2003035849A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237374A1 (en) 2002-06-04 2003-12-19 Centers For Disease Control And Prevention Improved pseudotyped retroviruses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5465899A (en) * 1998-08-04 2000-02-28 Purdue Research Foundation Pseudotyped retroviruses and stable cell lines for their production

Also Published As

Publication number Publication date
WO2003035849A2 (en) 2003-05-01
WO2003035849A3 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2002313559A1 (en) Genes
AU2002228492A1 (en) Annular array
AU2002357860A1 (en) Enzymes
AU2002301745A1 (en) Quick-Change Watchband
AU2001285693A1 (en) Bio-reactor
AU2002347778A1 (en) Enzymes
AU2002347813A1 (en) Chimeric viral vectors for gene therapy
AU2002242602A1 (en) Reactor
AU2002310296A1 (en) Rna purification methods
AU2002330401A1 (en) Gene overexpression system
AU2003273035A1 (en) Gene vaccine
AU2002348103A1 (en) Methods for gene transfer using pseudotyped lentiviruses
AUPR278301A0 (en) A novel gene
AU2003294705A1 (en) NtSM GENE
AU2002316788A1 (en) Retroviral vectors for gene therapy
AU2003237374A1 (en) Improved pseudotyped retroviruses
AU2003232606A1 (en) Surface reactor
AU2002332742A1 (en) Confirmation sequencing
AU2002306951A1 (en) Gene regulation ii
AU2003302040A1 (en) Novel cancer-associated gene
AU2002257273A1 (en) Enzymes
AUPR831301A0 (en) Toothbrush array
AUPS037102A0 (en) A novel gene
AUPR482001A0 (en) Metal-handling enzymes
AU2003241946A1 (en) Novel acylase gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase